Literature DB >> 18470735

Three cases of HIV-1 seroreversion.

V Tarján1, E Ujhelyi, J Szabó, R Kellner, G Krall, A Gyuris, I Mihály, G Füst.   

Abstract

Three patients were enrolled, two as hemophiliacs, and one with acute EBV infection. Serial serum samples of each patient were tested with at least 3 different HIV antibody EIA tests, an immunofluo-rescent test and two western blots (WB). In the third case, PCR and reverse transcriptase enzyme activity measurement were also done. One of the regularly checked serum samples of hemophiliac patients was reactive with different HIV screening and confirmatory assays. Their next blood samples, two weeks and one month later, respectively, were negative with the same tests. In Case 3. two and a half years after the first examination, the EIA tests results changed to negative, but the WB was still indeterminate. In the case of the two hemophiliac patients, the patients may have been exposed to HIV containing blood products (before 1985), but were not infected. Regular treatment with factor VIII concentrate, in which HIV antigens may be present, can boost the immune response and results in transient seropositivity. In the case of the EBV infected patient, the transient HIV seropositivity may be the consequence of EBV induced proliferation of anti-HIV-antibody producing B cell clones. During our ten year HIV confirmatory practice we tested more than 40000 samples, from which transient seropositivity were observed only in the three cases summarized in this paper.

Entities:  

Year:  1997        PMID: 18470735     DOI: 10.1007/BF02899926

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  11 in total

1.  Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention.

Authors:  B J Simpson; W A Andiman
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

2.  Absence of seroconversion of HIV-1 antibody in seroreactive individuals.

Authors:  S A Tenenbaum; C A Leissinger; R F Garry
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

3.  HIV clearance in infants--a continuing saga.

Authors:  Y J Bryson
Journal:  AIDS       Date:  1995-12       Impact factor: 4.177

4.  A solid phase reverse transcriptase micro-assay for the detection of human immunodeficiency virus and other retroviruses in cell culture supernatants.

Authors:  P A Somogyi; A Gyuris; I Földes
Journal:  J Virol Methods       Date:  1990-03       Impact factor: 2.014

5.  Prevalence of HIV-antibodies in patients with haemophilia in Hungary.

Authors:  E Ujhelyi; G Králl; G Füst; G A Medgyesi; S R Hollán; I Zimonyi; S Berkessy; K Nagy; I Földes; V Mayer
Journal:  Haematologia (Budap)       Date:  1988

6.  Absence of true seroreversion of HIV-1 antibody in seroreactive individuals.

Authors:  M J Roy; J J Damato; D S Burke
Journal:  JAMA       Date:  1993-06-09       Impact factor: 56.272

7.  Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study.

Authors:  H Farzadegan; M A Polis; S M Wolinsky; C R Rinaldo; J J Sninsky; S Kwok; R L Griffith; R A Kaslow; J P Phair; B F Polk
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

8.  Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV)

Authors:  S D Holmberg; C R Horsburgh; R H Byers; C A Schable; A R Lifson; G R Seage; E E Schoenbaum
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

9.  Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data.

Authors:  P A Roques; G Gras; F Parnet-Mathieu; A M Mabondzo; C Dollfus; R Narwa; D Marcé; J Tranchot-Diallo; F Hervé; G Lasfargues
Journal:  AIDS       Date:  1995-12       Impact factor: 4.177

10.  Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.

Authors:  H Burger; B Weiser; W S Robinson; J Lifson; E Engleman; C Rouzioux; F Brun-Vézinet; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.